Transform insight into action today
Connect with our team to tackle your toughest life sciences challenges with clarity, speed, and measurable impact.
Biography
Back to leadership team
About Maik
Over the past 20+ years I dedicated my career to rare diseases in international markets across a wide variety of consulting and entrepreneurial engagements.
Maik Klasen was one of the founding Managing Directors of Adivo Associates that is now Acumetis’ Insights and & Analytics. Maik started his career as an Immunologist and Geneticist at UCSF before entering the Biotech start up world via three California-based companies that were later divested. He continues to serve on the board of directors for another international BioPharma company, allowing him to follow a dual path as an entrepreneur and strategy consultant; roles that constantly expose him to new technologies and the impact they might have on transforming standards of care. Prior to founding Adivo, Maik was responsible for Frost & Sullivan’s Global Healthcare and Life Science Consulting Practice where he managed global consulting engagements with top 500 pharmaceutical, biotechnology, medical device, IVD/MDx and Healthcare IT companies.
Maik’s entrepreneurial approach and his ability to analyze both business and scientific issues allow him to converse with a broad range of audiences on many levels which is highly valued by his peers. Maik holds a magna cum laude Ph.D. in Immunogenetics in collaboration with the University of California, San Francisco and the Ludwig-Maximillians University in Munich, and a summa cum laude Masters in Molecular Biology from the University of Hannover, Germany. He is an alumni of the prestigious Boehringer Ingelheim Fonds.
Mike brings a wealth of experience and knowledge to the Acumetis team.
Professional skills and industry expertise
Leadership
- Insights and analytics practice lead
- Building and leading large international teams to be successful
Specialty
- Rare diseases of all kinds
- Auto-immunity and Immunology
- Oncology
- Pulmonology
Key Projects
- Corporate, BU, and brand strategy formulation and implementation
- M&A and licensing due diligence (buy- and sell-side) + post merger integration
- Market assessment, tracking, and forecasting
- HEOR projects enabled by RWE data
- Patient stratification
Therapeutic Areas
- Rare Diseases
Authored Posts